Reports indicate rising cases of microsporidial keratoconjunctivitis, suggesting urgent need for improved diagnosis and treatment practices.
In recent years, cases of microsporidial keratoconjunctivitis in China have been increasingly reported. Patients are often misdiagnosed as viral or fungal keratitis before confirmation, leading to prolonged disease course due to inappropriate treatment, and clinical awareness of this disease has long been insufficient. Current diagnosis and treatment face multiple challenges: limited understanding of the biological characteristics of microsporidia and risk factors such as parrot exposure, difficulty in clinical differentiation between keratoconjunctivitis and stromal keratitis types, and the absence of uniform diagnostic and therapeutic standards. It is imperative to strengthen clinical awareness of early diagnosis for patients with risk factors, promptly launch multicenter studies to establish standardized diagnostic and therapeutic consensus, so as to improve overall management and ensure patients receive timely and effective treatment.
No takes yet. Share an insight, caveat, or question.
Hong et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: